Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Enzyme-linked immunoassay method for quantitatively detecting content of anti-human interleukin 17 monoclonal antibody in serum

A monoclonal antibody and antibody technology, applied in the biological field, can solve the problems of low chromatography sensitivity, unstable recovery rate, cumbersome test process, etc.

Active Publication Date: 2021-02-23
QYUNS THERAPEUTICS CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The sensitivity of chromatography is low, the test process is cumbersome, and the recovery rate is unstable

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enzyme-linked immunoassay method for quantitatively detecting content of anti-human interleukin 17 monoclonal antibody in serum
  • Enzyme-linked immunoassay method for quantitatively detecting content of anti-human interleukin 17 monoclonal antibody in serum
  • Enzyme-linked immunoassay method for quantitatively detecting content of anti-human interleukin 17 monoclonal antibody in serum

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0150] Example 1 Preparation and Purification of Biotin-labeled Secondary Antibody

[0151] Anti-human interleukin-17 monoclonal antibody (F(ab) 2 ) as an antigen for rabbit immunization, and through B cell cloning technology to screen out the monoclonal antibody that can bind to the monoclonal antibody, does not block the binding of the anti-human interleukin-17 monoclonal antibody to its target human interleukin-17, and does not cross-react with other human IgG of the same type non-neutralizing rabbit monoclonal antibody.

[0152] After obtaining the above-mentioned anti-antibody light / heavy chain gene fragment and sequence information, first, design and synthesize the 3' end primer containing the Avi-Tag gene sequence; then use the PCR method to amplify and obtain the 3' end containing Avi-Tag sequence chain gene; by one-step cloning method, the heavy chain gene containing Avi-Tag was inserted into the expression plasmid to construct the heavy chain expression plasmid cont...

Embodiment 2

[0153] Embodiment 2 Carry out performance appraisal to the monoclonal antibody made by embodiment 1

[0154] 1. Identification of binding activity

[0155] Use anti-human interleukin-17 monoclonal antibody and human IgG as antigens to coat the enzyme-linked plate; make the serially diluted monoclonal antibody in Example 1 react with the coated antigen; sequentially add chromogenic antibody; substrate chromogenic solution; terminate solution; for binding activity experiments. The results showed that the monoclonal antibody had good binding activity to the anti-human interleukin-17 monoclonal antibody, and did not cross-react with isotype IgG.

[0156] 2. Identification of neutralizing activity

[0157] Use human interleukin-17 as an antigen to coat the enzyme-linked plate; add the incubation of the quantitative anti-human interleukin-17 monoclonal antibody and the serially diluted monoclonal antibody in Example 1 to react with the coated antigen; add the chromogenic antibody ...

Embodiment 3

[0160] Example 3 Using the "Secondary Antibody" Prepared in Example 1 to Construct an Elisa Kit

[0161] The antigen is interleukin-17 and is immobilized on the enzyme-linked plate; anti-human interleukin-17 monoclonal antibody can bind to the coated antigen; the "secondary antibody" prepared in Example 1 is used as the second antibody; horseradish peroxidase-labeled Streptavidin was used as a chromogenic antibody.

[0162] experiment procedure:

[0163] Coating: human interleukin-17 was diluted to 1 μg / ml with 1×PBS, 100 μl / well, and coated overnight at 2-8°C;

[0164] Blocking: 200 μl / well blocking solution, blocking at room temperature for 2 hours;

[0165] Adding samples: Dilute the MRD 20 times with the diluent before adding the standard and quality control samples; 100 μl / well, incubate at room temperature for 2 hours;

[0166] Add secondary antibody: add the "secondary antibody" prepared in Example 1 to diluent to 10ng / ml, 100μl / well, incubate at room temperature for...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an antibody; a heavy chain and a light chain; a corresponding variable domain and a corresponding complementary determining domain; and an enzyme-linked immunoassay assay method established using the antibody as a secondary antibody in BA-ELISA analysis.

Description

[0001] This case is a divisional application of an invention patent application with an application date of November 06, 2020, an application number of 202011233020.5, and an invention titled "An enzyme-linked immunoassay method for quantitative detection of anti-human interleukin-17 monoclonal antibody content in serum" . technical field [0002] The invention belongs to the field of biotechnology, and in particular relates to an enzyme-linked immunoassay method for quantitatively detecting the content of anti-human interleukin-17 monoclonal antibody in serum. Background technique [0003] Interleukin 17 (IL-17), also known as CTLA-8 or IL-17A, is a pro-inflammatory cytokine that stimulates non-immune cells such as fibroblasts, keratinocytes, epithelial and endothelial cells, synoviocytes, etc. to secrete IL-6 , IL-8, PGE2, MCP-1, CXCL-1 and G-CSF and other cytokines, and also has biological effects such as inducing ICAM-1 surface expression and T cell proliferation. IL-17...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/42G01N33/577G01N33/58
CPCC07K16/4241G01N33/577G01N33/581C07K2317/565C07K2317/56
Inventor 陈涛孙秋萍孔永陈卫朱云钱伟伦徐蕾
Owner QYUNS THERAPEUTICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com